Search Results

Containing any of the words

Only of the type

EPIK-B4: A Phase II, multicenter, randomized, open-label, active-controlled study to assess the safety and efficacy of dapagliflozin + metformin XR versus metformin XR during treatment with alpelisib (BYL719) in combination with fulvestrant in participants with HR+, HER2-, advanced Breast Cancer with a PIK3CA mutation following progression on/after endocrine-based therapy Drug Clinical Trial

Azathioprine Risk Minimization Activity - New

Mercaptopurine Risk Minimization Activity - New

Mercaptopurine Risk Minimization Activity - New

An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease Drug Clinical Trial

A Long-Term Extension Study of Nusinersen (BIIB058) Administered at Higher Doses in Participants With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen Drug Clinical Trial

(WU2249) NCMDR Weakly Update Medical Report

Approach of Dealing with Patents When Register Generic Drugs in SFDA Regulations

Drug Master File : Guidance for Submission Forms

Hydroxychloroquine Risk Minimization Activity